CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1 enrolled
Drug / intervention
Metal Stent (WallFlex™ Esophageal RX)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01899300
NCT01899300N/ACompleted
CompareCT.gov

A Multi-Center, Prospective, Evaluation of the Use of a Fully Covered Metal Stent (FCMS) for the Treatment of Refractory Benign Esophageal Strictures Caused by Caustic Ingestion

Boston Scientific Corporation·interventional·Posted Jul 15, 2013·Updated Feb 12, 2021

In Brief

A clinical study evaluating Metal Stent (WallFlex™ Esophageal RX) for Refractory Benign Esophageal Strictures Caused by Caustic Ingestion. Completed, enrolled 1 participant across 2 sites.

Detailed Summary

The purpose of this study is to establish clinical proof of concept of temporary indwell of the WallFlex™ Esophageal Fully Covered Metal Stent (FCMS) for the treatment of refractory benign esophageal strictures caused by caustic ingestion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractory Benign Esophageal Strictures Caused by Caustic Ingestion
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 15, 2013
Enrollment StartMar 1, 2015
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.0 years ago

Interventions

Metal Stent (WallFlex™ Esophageal RX)device